Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 638 (ZNF638) is a nucleoplasmic protein acting predominantly as a transcriptional cofactor and regulator of gene expression. It binds cytidine-rich sequences in double-stranded DNA utilizing multiple domains, including several C2H2-type zinc finger motifs, and is rapidly induced during adipocyte differentiation. ZNF638 interacts with key transcription factors such as C/EBPβ and C/EBPδ to enhance adipogenic transcriptional programs, principally stimulating the expression of peroxisome proliferator‐activated receptor γ (PPARγ) and promoting adipocyte-specific gene expression. In hepatocytes, ZNF638 participates in de novo lipogenesis via interactions with USP7, influencing the expression of major lipogenic enzymes. It is also involved in alternative splicing by interacting with splicing regulators and localizing to nuclear speckles. ZNF638 is associated with several diseases, including some cancers and metabolic syndromes; however, it is not currently a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 638 (ZNF638).